NCT06185296View on ClinicalTrials.gov

The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy

NANot yet recruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DEVICE

Intelligent telemonitoring

Telemonitoring using CGM, insulin pen data, and Fitbit data supported by data-driven decision support.

DEVICE

Telemonitoring

Telemonitoring using CGM, insulin pen data, and Fitbit data

Trial Locations (1)

9000

Department of Endocrinology, Aalborg

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

DexCom, Inc.

INDUSTRY

lead

Aalborg University Hospital

OTHER